Skip to main content

Genus Capital Management Inc.

Position in ABBV — AbbVie Inc.

CIK 1532385 VANCOUVER, A1

Position in ABBV

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$6,710,735
+$5,949,955 QoQ
Shares Held
26,668
+662.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.73%
of 13F equity value
Holder Rank
#1,134
of 4,153 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in ABBV Over Time

Shares Held

Position Value (USD)

Derivatives in ABBV

reported options exposure · as of Dec 31, 2024
CallValue
$0
CallShares
0
PutValue
$6,892,094
PutShares
38,785

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Genus Capital Management Inc. holds $47,435,252 across 7 Drug Manufacturers - General names. ABBV ranks #3 (14.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 ABBV
AbbVie Inc.
This page
26,668 $6,710,735

All Filings in ABBV

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,710,735 26,668
2026-03-31 $760,780 3,498
2025-12-31 $14,541,103 63,640
2025-09-30 $10,554,750 45,585
2025-06-30 $5,080,419 27,370
2025-03-31 $14,407,642 68,765
2024-12-31 $6,892,094 38,785
2024-09-30 $11,858,476 60,049
2024-06-30 $5,922,585 34,530
2024-03-31 $2,494,770 13,700